Trials / Completed
CompletedNCT00498303
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008
A Phase III, Multicenter, Uncontrolled, Open-Label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2007/2008 When Administered to Adult and Elderly Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Annual trial for registration of trivalent split influenza vaccine with the strain composition of the season 2007/2008 in healthy adult and elderly subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | trivalent split influenza vaccine |
Timeline
- Start date
- 2007-06-01
- First posted
- 2007-07-10
- Last updated
- 2008-04-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00498303. Inclusion in this directory is not an endorsement.